Pharmacy
BCBS is accusing Teva of offering coupons to prevent consumers from switching to a generic, lower-cost version of Copaxone.
Health officials are trying to move all vaccines to intradermal dosing as in a strategy to stretch supply.
Part D's programmatic structure may lead to plan sponsors preferring higher-cost versions of hepatitis C drugs, OIG finds.
This will increase the total number of doses available for use by up to fivefold, according to the agency.
The UnitedHealth Group subsidiary is working with the drugmaker to offer a 30-day supply of commonly used insulins for $35.
CMS anticipates releasing the 2023 premium and cost-sharing information for 2023 Medicare Advantage and Part D plans in September.
Equitable Breakthroughs in Medicine Development will get more underrepresented patients involved in the R&D of medical treatments.
The new order will begin arriving at the SNS in 2023, bringing the available supply of vaccine to treat monkeypox to nearly 7 million doses.
UHC frames the move as a push to reduce the burden of medical costs for consumers and to encourage better medication adherence.
The administration said this week that pharmacies are prohibited under law from discriminating based on race, sex, age and disability.